After Hours Summary: NVDA +4.2% higher on earnings; REGN +4.7% higher on FDA approval; PANW -3.4% lower on earnings
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: PACS +37.7%, CRNC +29.8%, KLIC +13.6%, NUTX +8.9%, ZTO +4.2% (also increases share repurchase authorization to $2 bln), NVDA +4.2%, CPA +0.4%
Companies trading higher in after hours in reaction to news: REGN +4.7% (FDA approves EYLEA HD Injection 8 mg), SMCI +3.7% (expands air-cooled AI solutions featuring AMD Instinct GPUs), MU +2.9% (in sympathy with NVDA earnings), AMD +2.9% (in sympathy with NVDA earnings), MRVL +2.3% (in sympathy with NVDA earnings), AVGO +2.1% (in sympathy with NVDA earnings), CDRE +1.3% (subsidiary awarded $50 mln contract with DoW), INTC +1.1% (in sympathy with NVDA earnings), PRI +1% (authorizes new $475 mln share repurchase program), XRX +0.8% (names new CFO), BF.A +0.1% (increases dividend)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: BV -7.1% (also increases share repurchase authorization to $150 mln), PANW -3.4% (also to acquire Chronosphere), JACK -1.9%, HI -0.6%, NJR -0.3%
Companies trading lower in after hours in reaction to news: SLMT -30.9% (stock offering by selling shareholders), VZLA -13.2% (convertible notes offering), NUVL -2% (FDA accepts NDA for zidesamtinib), ARMN -1.9% (long-term agreement with the Government of Colombia), HUHU -1.6% ($300 mln mixed shelf offering), GNK -1.4% (to acquire two Newcastlemax vessels), STEX -0.9% (stock offering by selling shareholders), RDVT -0.8% (stock offering by selling shareholders), AMGN -0.4% (FDA grants full approval to IMDELLTRA), CTGO -0.2% (starts Lucky Shot drill program), ULS -0.1% (development of new lab in Germany)